Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

United Arab Emirates

 

Revenue distribution of top 100 hospital groups in EMEA by country

This week’s infographic aggregates the 2024 total revenues of the top 100 hospital groups across Europe, the Middle East, and Africa, segmented by country, exposing distinct concentrations of market size and investment intensity.  The data has been sourced from the HBI Intelligence database. Germany commands a dominant position with €22.6 billion in hospital revenues, over […]

Exploring Saudi Arabia’s “completely different universe” for healthcare investors, with Youssef Haidar of Nexus Gulf

This interview features in the HBI 2025: Disruptive Innovation: Investing in Healthcare Transformation Conference Report, which was shared with conference delegates, and is available to HBI Deals and Insights and Intelligence members. Saudi Arabia’s rapidly developing private healthcare sector offers significant opportunities for international providers prepared to enter the country with the right partnerships, according […]

Circle’s new Middle Eastern owners boot out CEO and CFO

Circle Health Group, the UK’s largest for-profit hospital group, is undergoing a major management change. A spokesperson confirmed to HBI that the group’s CEO, CFO and General Counsel have all received the sack, as part of a strategy by its new UAE-based owners to “realise synergies” and “re-focus the business”.

FREE BLOG Blog: To Paris, and beyond!

There’s a palpable sense of purpose within the HBI team, who I can report are relishing the prospect of hosting the industry we serve in Paris for the very first time later this month. If you’re reading this and haven’t yet got your ticket, it’s not too late to book now. Please join us for […]

UAE launches nationwide health insurance scheme

A basic health insurance package for private sector employees and domestic workers who are not currently covered by insurance is to be launched across the UAE, the Ministry of Human Resources and Emiratisation (MoHRE) announced.

Exploring the GCC’s prospective $11 billion GLP-1 RA market — ‘a unique opportunity to lead in this space’

Demand for GLP-1 receptor agonists (the class of drugs used to treat obesity and diabetes) has been growing rapidly, opening up more and more opportunities in the market, such as ‘holistic’ online prescription services. We’ve seen both the positives and negatives of the use of GLP-1 RAs in the US and Europe, from transforming people’s health for the better to misuse and inappropriate supply. But what do we know about the market in the Middle East?

Find Us